- Home
- RANI vs BWG Comparison
RANI vs BWG Comparison
Compare RANI & BWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RANI | BWG |
|---|---|---|
| Founded | 2012 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.8M | 131.0M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | RANI | BWG |
|---|---|---|
| Price | $0.82 | $7.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 983.3K | 103.1K |
| Earning Date | 03-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.37% |
| EPS Growth | ★ 57.14 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,633,000.00 | N/A |
| Revenue This Year | $321.62 | N/A |
| Revenue Next Year | $74.26 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 58.85 | N/A |
| 52 Week Low | $0.39 | $7.46 |
| 52 Week High | $3.87 | $8.94 |
Technical Indicators
Market Signals| Indicator | RANI | BWG |
|---|---|---|
| Relative Strength Index (RSI) | 23.41 | 24.11 |
| Support Level | $0.46 | N/A |
| Resistance Level | $0.87 | $8.58 |
| Average True Range (ATR) | 0.09 | 0.10 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 0.02 | 1.96 |
Price Performance
Historical ComparisonAbout RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
About BWG BrandywineGLOBAL Global Income Opportunities Fund Inc.
BrandywineGLOBAL - Global Income Opportunities Fund Inc is a non-diversified, closed-end management investment company. The primary investment objective is to provide current income. The secondary investment objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing, under normal market conditions, at least 80% of its assets in world-wide fixed-income securities.